AIM
NXTM

Acrospire Investment Management’s NxStage Medical Inc. NXTM Stock Holding History

Acrospire Investment Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-262
Closed -$7K – 1905
2017
Q2 		$7K Sell
262
-1,400
-84% -$34.7K 0.01% 1906
2017
Q1 		$45K Sell
1,662
-5,996
-78% -$166K 0.04% 1051
2016
Q4 		$201K Buy
7,658
+1,080
+16% +$26.7K 0.08% 359
2016
Q3 		$164K Buy
6,578
+1,900
+41% +$44.3K 0.11% 235
2016
Q2 		$101K Buy
4,678
+4,378
+1,459% +$78.1K 0.08% 447
2016
Q1 		$4K Buy
+300
New +$5.03K ﹤0.01% 1904

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Acrospire Investment Management's NXTM Position: Q3 2017 in Review

Acrospire Investment Management sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 262 shares — an estimated $7K sold.

Acrospire Investment Management first reported a position in NXTM in Q1 2016 and held it in 6 quarters. The position peaked at $201K in Q4 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Acrospire Investment Management reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 262 NxStage Medical Inc. shares in Q3 2017, an estimated $7K.
  • Acrospire Investment Management first reported a position in NxStage Medical Inc. in Q1 2016 and held it in 6 quarters.
  • Acrospire Investment Management's NxStage Medical Inc. position peaked at $201K in Q4 2016.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.